期刊文献+

急性心肌梗死患者血清N末端B型钠尿肽检测在左室重构中的预测价值 被引量:6

Predictive value of serum N-tenninal pro-brain natriuretic peptide in acute myocardial infarction patients for left ventricular remodeling
原文传递
导出
摘要 目的观察AMI患者发病第3天血清NT-proBNP水平与其左室重构之间的关系,评价其对AMI后左室重构的预测价值。方法以急性心肌梗死(AMI)发病第3天与3个月时患者的左心室舒张末期内径之差(△LVDd)>5 mm以及发病3个月时左心室射血分数(LVEF)≤40%作为发生心脏左室重构的依据。采用免疫电化学发光法测定106例患前壁、前间壁及前侧壁AMI的患者第3天血清NT-proBNP水平,分别对患者第3天和3个月时行超声心动描述术检测LVDd和LVEF水平。结果AMI患者第3天血清NT-proBNP均值是1039.28(241.50~1184.25)ng/L。AMI患者第3天和3个月时LVDd由(50±5)mm升至(53±7)mm(P<0.05),LVEF由(53±8)%升高为(54±11)%(P>0.05)。AMI后第3天NT-proBNP浓度与△LVDd呈显著正相关r=0.403(P<0.05),与LVEF呈显著负相关r=-0.395(P<0.01);ROC曲线分析表明以AMI发病3个月间△LVDd>5 mm作为发生左室重构的依据,曲线下面积(AUC)为0.894;以AMI发病3个月时LVEF≤40%作为发生左室重构的依据,则AUC为0.873;以AMI发病3个月间ALVDd>5 mm和3个月时LVEF≤40%作为发生左室重构的依据,则AUC为0.893。结论AMI患者第3天血清NT-proBNP水平可作为预测AMI晚期的左室重构指标之一。 Objective To evaluate the forecasting capability of serum N-terminal pro-brain natriuretic peptide (NT-proBNP) level for Left ventricular (LV) remodeling of patients with acute myocardial infarction (AMI) through observation of the relationship between serum NT-proBNP on the 3rd day and LV remodeling following onset of AMI. Methods Electrochemilumin-escence was adopted to determine the serum NT-proBNP level on the 3rd day after AMI attack for 106 cases of patients with anterior, anteroseptal and anterolateral AMI, with echocardiography performed to detect LV end-diastolic diameter (LVDd) and lefiventricular ejection fraction (LVEF) respectively on the 3rd day and 3 months after the attack. Results The serum NT-proBNP level of AMI patients on the 3rd day averaged 1039. 28 ( 241.50- 1 184. 25) ng/L. For AMI patients on the 3rd day and 3 months after, LVDd rose to (53 ±7) mm (P 〈 0.05) from (50 ±5) mm, and LVEF to (54 ± 11) % (P〉0.05) from (53±8) %. NT-proBNP concentration on the 3rd day after AMI onset was positively correlated with △LVDd significantly,r = 0. 403 ( P 〈 0. 05 ) , while negatively correlated with LVEF significantly, r = - 0. 395 ( P 〈 0. 01 ). Analysis by ROC curve showed that if LV remodeling was decided when ALVDd ( 5ram during the 3 months after AMI onset, AUC ( area under ROC curve) was 0. 894, if decided when LVEF ≤40 % at the 3rd month after the onset, AUC was 0. 873, and if decided when △LVDd 〉 5ram during the 3 months and LVEF at the 3rd month ≤〈40 % , AUC was 0. 893. Conclusion The test results showed serum NT-proBNP level for AMI patients on the 3rd day may be used as one of forecasting indexes of LV remodeling for AMI of advanced stage.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2006年第7期604-607,共4页 Chinese Journal of Laboratory Medicine
关键词 钠尿肽 心肌梗塞 超声心动描记术 Natriuretic peptide Myocardial infarction Echocardiography
  • 相关文献

参考文献4

二级参考文献41

  • 1钟优,冯新恒,毛节明.氮末端脑钠素前体评价急性心肌梗死后左心室功能及重构[J].中国循环杂志,2004,19(5):325-327. 被引量:14
  • 2史晓敏,林箐,徐国宾,宋以信,夏铁安.血清N末端B型钠尿肽原在心功能评价及慢性充血性心力衰竭诊断中的初步应用[J].中华检验医学杂志,2005,28(1):37-41. 被引量:77
  • 3Bettencourt P, Ferreira A, Dias P, et al. Evaluation of brain natriuretic peptide in the diagnosis of heart failure. Cardiology,2000,93 : 19-25.
  • 4Pemberton CJ, Johnson ML, Yandle TG, et al. Deconvolution analysis of cardiac natriuretic peptides during acute volume overload.Hypertension ,2000,36 : 355-359.
  • 5Hammerer-Leacher A, Neubauer E, Muller S, et al. Head-to-head comparison of N-temfinal pro-brain natriuretic peptide, brain natriuretic pepfide and N-temlinal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta, 2001,310:193-197.
  • 6Redfield MM, Rodeheffer R J, Jacobsen S J, et al. Plasma brain natriuretic peptide concentration : impact of age and gender. J Am Coll Cardiol,2002 ,40 :976-982.
  • 7Richards AM, NichoUs MG, Espiner EA, et al. B -type natriuretic peptides and ejectionfraction for prognosis after myocardial infarction. Circulation, 2003,107:2786-2792.
  • 8Yoshihiko S, Teruyo Y. Application of NT-proBNP and BNP measurements in care : a more discerning marker for the detection and evaluation of heart failure. The European Journal of heart Failure,2004. 295-300.
  • 9Cowie MR, Struthers AD, Wood DA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet, 1997,350 : 1349-1353.
  • 10MeDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of lefi-ventricular systolic dysfunction. Lancet, 1998,351 : 9-13.

共引文献125

同被引文献64

引证文献6

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部